Cart
Free US shipping over $10
Proud to be B-Corp

Onco-Nephrology Summary

Onco-Nephrology by Kevin W. Finkel (Professor and Clinical Vice-Chairman of Medicine Director, Division of Renal Diseases & Hypertension Chief, Section of Critical Care Nephrology, University of Texas Medical School, Houston, TX, USA)

Kidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, Onco-Nephrology provides authoritative, definitive coverage of the mechanism and management of these two life-threatening diseases. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed. Addresses acute and chronic kidney diseases that develop from a variety of cancers. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy. Discusses key issues regarding kidney disease in patients with cancer, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer. Contains dedicated chapters for each class of the conventional chemotherapeutic agents, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment. Includes special chapters devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses increasingly complex problems due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care. Covers anti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies - treatments that are being recognized for adverse kidney effects. Utilizes a clear, logical format based on the ASN Core Curriculum for Onco-Nephrology, making this reference an excellent tool for board review, as well as a practical resource in daily practice. Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

About Kevin W. Finkel (Professor and Clinical Vice-Chairman of Medicine Director, Division of Renal Diseases & Hypertension Chief, Section of Critical Care Nephrology, University of Texas Medical School, Houston, TX, USA)

Professor of Medicine (Nephrology); Director, Acute Dialysis Unit, Yale School of Medicine, New Haven, Connecticut

Table of Contents

SECTION 1 Fluid and Electrolyte Disorders in Cancer Patients 1 Kidney Function 2 Dysnatremias in Cancer 3 Potassium Disorders 4 Calcium and Phosphorus Disorders 5 Volume Disorders and Fluid Resuscitation SECTION 2 Paraprotein-Related Kidney Diseases 6 Paraproteins 7 Cast Nephropathy 8 Systemic Light Chain Amyloidosis 9 Monoclonal Immunoglobulin Deposition Disease 10 Fibrillary and Immunotactoid Glomerulonephritis SECTION 3 Hematopoietic Stem Cell Associated Kidney Disease 11 Hematopoietic Cell Transplant Associated Kidney Injury 12 Sinusoidal Obstruction Syndrome 13 Thrombotic Microangiopathy 14 Graft-Versus-Host Disease 15 Chronic Kidney Disease, End-Stage Renal Disease, and Bone Marrow Transplant SECTION 4 Chemotherapy and Radiation Related Kidney Diseases 16 Conventional Chemotherapy 17 Targeted Cancer Therapies (Biologics) 18 Adverse Kidney Effects of Immunotherapies 19 Chemotherapy in Chronic Kidney Disease and Dialysis 20 Radiation Nephropathy SECTION 5 Paraneoplastic Glomerulopathies 21 Paraneoplastic Glomerular Diseases 22 Paraneoplastic Glomerulonephritis 23 Hematologic Malignancies 24 Cancer Screening Recommendations SECTION 6 Renal Tumors 25 Renal Cell Cancer 26 Wilms Tumor and von Hippel Lindau Disease 27 Tuberous Sclerosis Complex and the Kidney 28 Evaluation of a Renal Cyst/Mass SECTION 7 Acute Kidney Injury 29 Acute Kidney Injury Incidence, Pathogenesis, and Outcomes 30 Tumor Lysis Syndrome 31 Obstructive Nephropathy in Cancer 32 Renal Replacement Therapies SECTION 8 Chronic Kidney Disease and Cancer 33 Chronic Kidney Disease as a Complication of Cancer, With Special Focus on Kidney and Urothelial Tumors 34 Incidence of Cancer and Screening Recommendations 35 Cancer in Renal Transplant Patients SECTION 9 Kidney Infections 36 Renal Infections in Cancer Patients SECTION 10 Infiltrative Diseases 37 Kidney Disease in Leukemia 38 Kidney Disease in Lymphoma

Additional information

NPB9780323549455
9780323549455
0323549454
Onco-Nephrology by Kevin W. Finkel (Professor and Clinical Vice-Chairman of Medicine Director, Division of Renal Diseases & Hypertension Chief, Section of Critical Care Nephrology, University of Texas Medical School, Houston, TX, USA)
New
Hardback
Elsevier - Health Sciences Division
2019-08-22
384
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Onco-Nephrology